Natural Capsules partly paid (Delisted) results

BSE: 890161Pharmaceuticals & Biotechnology

Last traded ₹462.55 on 9 Nov 2022

Delisted. The company's shares trade as Natural Capsules (NATCAPSUQ).

Q4 results, quarter to Mar 2022

Consolidated: the company and its subsidiaries together. ₹ crore.Natural Capsules partly paid annual results and balance sheet

Revenue
₹42 Cr+10.5% on the quarter before
Operating profit
₹8.13 Cr+5.9% on the quarter before
Net profit
₹5.12 Cr+24.9% on the quarter before
Earnings per share
₹7.02+20.0% on the quarter before
Operating margin
19.6%
Net margin
12.3%

From revenue to net profit, ₹ crore

  1. Revenue42
  2. Materials and goods−19
  3. Employee costs−2.4
  4. Other expenses−12
  5. Operating profit8.1
  6. Depreciation−1.4
  7. Other income+0.8
  8. Finance costs−0.7
  9. Profit before tax6.9
  10. Tax−1.8
  11. Net profit5.1

Natural Capsules partly paid results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Mar 2022. Results for the quarter to Jun 2022 were due by 14 Aug 2022, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreDec 2021Q3Filed 8 FebMar 2022Q4Filed 12 May
Revenue from operations37.641.6
29.933.4
Materials and goods bought15.918.6
Employee costs2.62.4
Other expenses11.412.5
Operating profit before depreciation7.78.1
Operating margin20.4%19.6%
Depreciation and amortisation1.31.4
Other income0.10.8
Finance costs0.60.7
One-off items0.00.0
Profit before tax5.96.9
1.81.8
Tax rate30.7%25.6%
Net profit4.15.1
Other comprehensive income0.0−0.2
Total comprehensive income4.14.9
Net margin10.9%12.3%
Earnings per share₹5.85₹7.02
Earnings per share in rupees, restated for later splits and bonuses.